Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;32(10):2692-2703.
doi: 10.1111/jce.15213. Epub 2021 Aug 26.

Safety and feasibility of conduction system pacing in patients with congenital heart disease

Affiliations

Safety and feasibility of conduction system pacing in patients with congenital heart disease

Óscar Cano et al. J Cardiovasc Electrophysiol. 2021 Oct.

Abstract

Introduction: Conduction system pacing (CSP) has emerged as an ideal physiologic pacing strategy for patients with permanent pacing indications. We sought to evaluate the safety and feasibility of CSP in a consecutive series of unselected patients with congenital heart disease (CHD).

Methods: Consecutive patients with CHD in which CSP was attempted were included. Safety and feasibility, implant tools and electrical parameters at implant and at follow-up were evaluated.

Results: A total of 20 patients were included (10 with a previous device). A total of 10 patients had complex forms of CHD, 9 moderate defects and 1 a simple defect. CSP was achieved in 75% of cases (10 His bundle pacing, 5 left bundle branch pacing) with left ventricular septal pacing in the remaining 5 patients. Procedure times and fluoroscopy times were prolongued (126 ± 82 min and 27 ± 30 min, respectively). Ventricular lead implant times widely varied ranging from 4 to 115 min, (mean 31 ± 28 min) and the use of multiple delivery sheaths was frequent (50%). The QRS width was reduced from 145 ± 36 ms at baseline to 116 ± 18 ms with CSP. Implant electrical parameters included: CSP pacing threshold 0.95 ± 0.65 V; R wave amplitude 9.2 ± 8.8 mV and pacing impedance 632 ± 183 Ohms, and remained stable at a median follow-up of 478 days (interquartile range: 225-567). Systemic ventricle systolic function and NYHA class (1.50 ± 0.51 vs. 1.10 ± 0.31; p = .008) significantly improved at follow-up. Lead revision was required in one patient at Day 4.

Conclusions: Permanent CSP is safe and feasible in patients with CHD although implant technique is complex.

Keywords: His bundle pacing; conduction system pacing; congenital heart disease; left bundle branch area pacing.

PubMed Disclaimer

References

REFERENCES

    1. Abdelrahman M, Subzposh FA, Beer D, et al. Clinical outcomes of his bundle pacing compared to right ventricular pacing. J Am Coll Cardiol. 2018;71:2319-2330.
    1. Chen X, Jin Q, Bai J, et al. The feasibility and safety of left bundle branch pacing vs. right ventricular pacing after mid-long-term follow-up: a single-centre experience. Europace. 2020;22(Suppl_2):ii36-ii44. https://doi.org/10.1093/europace/euaa294. PMID: 33370799.
    1. Upadhyay GA, Vijayaraman P, Nayak HM, et al. His-SYNC Investigators. His corrective pacing or biventricular pacing for cardiac resynchronization in heart failure. J Am Coll Cardiol. 2019;74:157-159.
    1. Huang W, Su L, Wu S, et al. Long-term outcomes of His bundle pacing in patients with heart failure with left bundle branch block. Heart. 2019;105:137-143.
    1. Vijayaraman P, Herweg B, Dandamudi G, et al. Outcomes of His-bundle pacing upgrade after long-term right ventricular pacing and/or pacing-induced cardiomyopathy: insights into disease progression. Heart Rhythm. 2019;16:1554-1561.

LinkOut - more resources